Approval for 1 (one) year shelf-life, the incorporation of additional electrodes for stimulation and mapping (10 electrodes total), and other minor device modifications.  The device as modified, will be marketed under the trade name livewire tc compass catheter and is indicated for use for cardiac electrophysiological. mapping and for use with a compatible rf generator for: interruption of accessory atrioventricular (av) conduction pathways associated with tachycardia; the treatment of av nodal block re-entrant tachycardia (avnrt); or creation of completion av nodal block in patients with difficult to control ventricular to an atrial arrhythmia.